{
    "nctId": "NCT03120728",
    "officialTitle": "AFTER: Application for the Etonogestrel/Ethinyl Estradiol Ring--potential for Emergency Contraception",
    "inclusionCriteria": "* Healthy, women ages 18 to 39yo with BMI \\<30\n* Regular menstrual cycles with duration between 24-35 days\n* Completion of screening visit where ovulation will be assessed with blood draw for progesterone level (must be 5ng/mL or greater)\n* Not seeking pregnancy during the study period\n* Use of a non-hormonal form of contraception, such as: sterilization (tubal ligation, Essure), copper IUD (intrauterine device), barrier methods or abstinence\n* Must speak English or Spanish\n* Must be FEMALE\n* Must have minimum age of 18 Years\n* Must have maximum age of 39 Years",
    "exclusionCriteria": "* Currently pregnant or breastfeeding\n* Severe pelvic organ prolapse or prolapse to any degree that may prevent retention of the vaginal ring after insertion\n* Use of oral contraceptive pills, patches, implants or hormonal intrauterine contraception in the month prior to screening\n* Use of depo medroxyprogesterone within 6 months of screening\n* Use of medications that interact with contraceptive steroid hormones: anti-epileptic medications, rifampin, rifabutin, fosamprenavir, etc\n* Medical condition with safety deemed to be category 3 or 4 when using a combined hormonal contraceptive, as determined by the Center for Disease Control Medical Eligibility Criteria: current or past history of breast cancer, severe decompensated cirrhosis, history of deep vein thrombosis or pulmonary embolus, diabetes with nephropathy/retinopathy/neuropathy or other vascular disease diagnosed more than 20 years ago, current symptomatic gallbladder disease, hypertension, ischemic heart disease, known thrombogenic mutations, hepatocellular adenoma, malignant hepatoma, multiple risk factors for atherosclerotic cardiovascular disease, multiple sclerosis with prolonged immobility, history of peripartum cardiomyopathy, cigarette smoking and \u226535yo, history of complicated solid organ transplant, history of stroke, history of superficial venous thrombosis not associated with catheter, systemic lupus erythematosus with positive antiphospholipid antibodies, valvular heart disease complicated by pulmonary hypertension or atrial fibrillation or bacterial endocarditis, and acute viral hepatitis"
}